Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
MaxCyte, Inc. (NASDAQ: MXCT)
MXCT Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
17.70%
Analyst Rating:
BUY
Analyst Forecast (1yr):
129.20%
MXCT Stock Analysis
MXCT
PE Ratio:
MXCT
PEG Ratio:
Not Available
MXCT
Forward EPS Growth (12 month):
0.00%
MXCT
PS Ratio:
4
MXCT
PSG Ratio:
0.2
MXCT
Forward Revenue Growth (12 month):
21.80%
MXCT Articles
No data was found